- Embraer delivered 30 jets in the first quarter of 2025, representing a 20% increase compared to the same period last year when they delivered 25 jets.
- The company delivered 7 commercial jets, slightly short of the estimated 9.8.
- Deliveries included 23 executive jets, exceeding the estimate of 21.
- For the year 2025, Embraer anticipates delivering between 77 and 85 commercial aircraft.
- The company projects delivering between 145 and 155 executive aircraft in 2025.
- Current stock recommendations for Embraer include 2 buys, 2 holds, and 1 sell.
A look at Embraer SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores have given Embraer SA a positive long-term outlook. With high scores in Growth and Momentum, the company is positioned for future expansion and market performance. Embraer’s focus on innovation and product development has earned it a strong score in Growth, indicating potential for increased market share and revenue growth. Additionally, its Momentum score highlights strong investor interest and market confidence in the company’s direction.
Despite lower scores in Value and Dividend, Embraer SA‘s overall outlook remains optimistic. The company’s resilience score of 4 suggests a stable and adaptable business model, able to withstand market challenges. Embraer’s strategic positioning in manufacturing and servicing commercial, corporate, and defense aircraft, along with its targeted marketing approach, contributes to its favorable long-term prospects in the aerospace industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
